Brain Metastases - Raizer, Jeffrey J. / Abrey, Lauren E. (eds.)
110,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
55 °P sammeln
  • Gebundenes Buch

Brain metastases are the most dreaded complication of systemic cancer, affecting approximately 170,000 people a year, a far greater incidence than primary brain tumors. Advances in modern chemotherapy have led to an improved control of system cancers, often with agents that poorly penetrate the central nervous system, resulting in an increasing incidence of brain metastases. Traditional chemotherapy has had little impact on brain metastases. The main therapeutic option is radiation therapy, and in a small number of patients - surgery. However, refinements in all of these treatments offer some…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Brain metastases are the most dreaded complication of systemic cancer, affecting approximately 170,000 people a year, a far greater incidence than primary brain tumors. Advances in modern chemotherapy have led to an improved control of system cancers, often with agents that poorly penetrate the central nervous system, resulting in an increasing incidence of brain metastases. Traditional chemotherapy has had little impact on brain metastases. The main therapeutic option is radiation therapy, and in a small number of patients - surgery. However, refinements in all of these treatments offer some positive outcomes and an increased ability to stratify patients based on certain criteria.

This book will bring current information on the presentation and management of patients with brain metastases, providing available data, giving guidelines that can be applied in day to day practice, updated information for neuro-surgeons, radiation oncologists, medical oncologists, and neuro-oncologists, as well as an overview for physicians in training.
Rezensionen
From the reviews:

"This book addresses some of the most important aspects in dealing with central nervous system metastases. The purpose is to address management of brain metastases. Neurologists, neurosurgeons, and oncologists are the main audience for this book. The 12 chapters written by 24 contributors provide accurate, up-to-date, and well illustrated information on chemotherapeutic drugs and surgical, and radiosurgical protocols. ... This is an excellent book for neurology, neurosurgery, and oncology libraries." (Celso Agner, Doody's Review Service, November, 2007)